Israel Englander Aprea Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$0.32 - $15.2 $13,853 - $658,053	43,293 Added 35.68%	164,626 $53,000
Q3 2022 Nov 14, 2022	BUY	$0.71 - $13.6 $78,865 - $1.51 Million	111,078 Added 1083.16%	121,333 $79,000
Q2 2022 Aug 15, 2022	BUY	$0.62 - $1.94 $6,358 - $19,894	10,255 New	10,255 $8,000
Q3 2021 Nov 15, 2021	SELL	$3.43 - $5.63 $113,886 - $186,932	-33,203 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.05 - $5.5 $134,472 - $182,616	33,203 New	33,203 $162,000
Q1 2021 May 17, 2021	SELL	$4.73 - $8.15 $455,153 - $784,250	-96,227 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.92 - $30.67 $374,264 - $2.33 Million	76,070 Added 377.39%	96,227 $473,000
Q3 2020 Nov 16, 2020	SELL	$21.66 - $38.86 $3,422 - $6,139	-158 Reduced 0.78%	20,157 $485,000
Q2 2020 Aug 14, 2020	BUY	$25.47 - $39.69 $517,423 - $806,302	20,315 New	20,315 $788,000
Q1 2020 May 14, 2020	SELL	$31.65 - $45.3 $200,755 - $287,337	-6,343 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $120,136 - $314,168	6,343 New	6,343 $291,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,741
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.